» Articles » PMID: 33893721

Adipocyte Proteins and Storage of Endogenous Fatty Acids in Visceral and Subcutaneous Adipose Tissue in Severe Obesity

Overview
Date 2021 Apr 24
PMID 33893721
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: This study tested whether substrate concentrations or fatty acid storage proteins predict storage of endogenous lipids in visceral adipose tissue (VAT) and upper body subcutaneous adipose tissue (UBSQ) fat.

Methods: The day prior to surgery, 25 patients undergoing bariatric procedures received an infusion of autologous [1- C]triolein-labeled very low-density lipoprotein (VLDL) particles, and during surgery, they received a continuous [U- C]palmitate infusion/bolus [9,10- H]palmitate tracer. VAT and UBSQ fat were collected to measure VLDL-triglyceride (TG) storage, direct free fatty acid (FFA) storage rates, CD36 content, lipoprotein lipase (LPL), acyl-CoA synthetase, diacylglycerol acetyl-transferase, and glycerol-3-phosphate acyltransferase activities.

Results: Storage of VLDL-TG and FFA-palmitate in UBSQ and VAT was not different. Plasma palmitate concentrations correlated with palmitate storage rates in UBSQ and VAT (r = 0.46, P = 0.02 and r = 0.46, P = 0.02, respectively). In VAT, VLDL-TG storage was correlated with VLDL concentrations (r = 0.53, P < 0.009) and LPL (r = 0.42, P < 0.05). In UBSQ, VLDL-TG storage was correlated with LPL (r = 0.42, P < 0.05). CD36, acyl-CoA synthetase, glycerol-3-phosphate acyltransferase, and diacylglycerol acetyl-transferase were not correlated with VLDL-TG or palmitate storage.

Conclusions: Adipose storage of VLDL-TG is predicted by VLDL-TG concentrations and LPL; FFA concentrations predict direct adipose tissue FFA storage rates.

Citing Articles

Similar insulin regulation of splanchnic FFA and VLDL-TG in men with nonalcoholic hepatic steatosis and steatohepatitis.

Risikesan J, Heeboll S, Kumarathas I, Sondergaard E, Johansen R, Ringgaard S J Lipid Res. 2024; 65(7):100580.

PMID: 38901559 PMC: 11301221. DOI: 10.1016/j.jlr.2024.100580.


Clinically Effective Molecules of Natural Origin for Obesity Prevention or Treatment.

Hidalgo-Lozada G, Villarruel-Lopez A, Nuno K, Garcia-Garcia A, Sanchez-Nuno Y, Ramos-Garcia C Int J Mol Sci. 2024; 25(5).

PMID: 38473918 PMC: 10931663. DOI: 10.3390/ijms25052671.


A long-term anti-inflammation markedly alleviated high-fat diet-induced obesity by repeated administrations of overexpressing IL10 human umbilical cord-derived mesenchymal stromal cells.

Wang L, Gao T, Li Y, Xie Y, Zeng S, Tai C Stem Cell Res Ther. 2022; 13(1):259.

PMID: 35715850 PMC: 9204983. DOI: 10.1186/s13287-022-02935-8.

References
1.
Bush N, Triay J, Gathaiya N, Hames K, Jensen M . Contribution of very low-density lipoprotein triglyceride fatty acids to postabsorptive free fatty acid flux in obese humans. Metabolism. 2013; 63(1):137-40. PMC: 3859725. DOI: 10.1016/j.metabol.2013.09.008. View

2.
Heiling V, Miles J, Jensen M . How valid are isotopic measurements of fatty acid oxidation?. Am J Physiol. 1991; 261(5 Pt 1):E572-7. DOI: 10.1152/ajpendo.1991.261.5.E572. View

3.
Shadid S, Koutsari C, Jensen M . Direct free fatty acid uptake into human adipocytes in vivo: relation to body fat distribution. Diabetes. 2007; 56(5):1369-75. DOI: 10.2337/db06-1680. View

4.
Tchoukalova Y, Harteneck D, Karwoski R, Tarara J, Jensen M . A quick, reliable, and automated method for fat cell sizing. J Lipid Res. 2003; 44(9):1795-801. DOI: 10.1194/jlr.D300001-JLR200. View

5.
Gormsen L, Nellemann B, Sorensen L, Jensen M, Christiansen J, Nielsen S . Impact of body composition on very-low-density lipoprotein-triglycerides kinetics. Am J Physiol Endocrinol Metab. 2008; 296(1):E165-73. DOI: 10.1152/ajpendo.90675.2008. View